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CLINICA， L EFFECT OF NEW cr－ADRENERGIC BLOCKER ．ON
MICTURITIeN DISTURBANCE OF NEUROGENIC BLADDER
      AND LOWER URINARY TRACT OBSTRUCTION・
   Yvtkie TAKrMdTo， Kazuko KiTAMuRA， Takuro FusE，
KazUhisa KAwAzoE， Daisaku HiRANo， Tatsuo AMAGAi and
Shuji KiyotAKI’
  舟・m彦ん・Dψ・伽・・‘げ伽♂・9］，＆h・・1 Of Medi甑磁θ・翫燃吻
              （Direc鰍Pπゾ1丑Kis伽・‘0ノ
   E－643， a”netvly deve16ped ai－adrepergic blocker with a postsynaptic action， was tried on 17 sub－
jects， 10．patients with neurogenic bladder and 7 patients with lower urethral obstruction． The results
of treatment wgge exc．ellent in 5， good in 7， and pobr in 5 of them， the rate of effectiveness therefore
being 70．60／o． 一The inhibitory effect．of E－643 on the contractility of the detrusor was no strQnger
than’ that of other a．blockers．
   The rate ofeffectiveness for neurogenic bladders was as high qs 800／． ．whereas that fOr lower urethral
obstruction was much lower： 570／，． Concerning benign prostat’ic hyperplasia （B．P．H） alone， this
agent’was markedly beneficial．・ ln the case of B，P．H the urethta presSure in the prostatic urethra
tends to drop and urination is facilitated even without a change in maxiinum urethral closure Pressure，
which reduces the amount of residual urine， this sequence of events taking place on condition that
the contractility of the detrusor is adequate．
   According to urodynamic criteria， the underlying causes ofthe so－called bladder neck contracture
CanD． b．9 ．9．1，4F．Eifi，．9． djP．t．9 P． 1， g． ，ap． ．i．g． ｛ ．p．．．q．． 9．gnf S，if p．4．1．・ f Pgtructiop， but it is mistaken・ to use this tgrm for func－
tional ． d’奄唐狽浮窒b?撃?メfe’ ’6f’ th6． bladdler”heck． ’lt’ Seeins ．Worthwhile t6 detgrmine the clinical effect of a－
blockers・’on ・fun’ctiohal urethral obStrUctibn．
   E－643 produced few if any apprgciablg signs or symptgms of side effects either subjectiyely or
objectively．
Key words： evi－adrenergic blocker， Neurogenic’bladder， Urodynamics， U．P．P．， Bladder neck obstruc－
         tion’















































































































































































































































症  残尿（m2） MUCP（c咄O）効
例 前  後  前  後 果
併用または     副作用後療法
1 400t 60 43．2
2 700 30 67．6
3螺照乳）24．3
4 130 30－50 20．3
5 500t O 50．0
6 800 500 31．1
7   270   120   25。フ
8 240 45 23．0
9 300 300 16．2
10 320 300 25．7
11 580 5Ge 23．0
12  1ア0   70   36．5
13 350 130 56．8
14 480 50 59．5
15 1640 300 27．0
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計 5  7  5 17
Table 4．膀胱内圧曲線と効果（17例）
内圧曲線  著効 有効 無効計
正 緊張型
高緊張型低緊張型無緊．張型
1   2 0  3
1   2 0  3
2   3 3  8
1   0 2  3
計 5   7   5  17
Table 5． MUCPと効果（14例）
MUCP著効 有効 無効 計
下  降  群  5
不  変  群  0
2 0  7
5 2  7





















    B・ P． pulse
症例   mmHg
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   （山田＝または山田・ほか：）と，2語（例：前
  立腺がん・PSAP）からなるrunning titleお
   よび5語（英文）以内のkey wordsを付す、
 ＠ 英文抄ee ；ダブルスペースでタイプし，その
  和訳をつける．
（3）英文原稿はダブルスペースでタイプし，原稿の
 表紙に標題，著者名，所属機関名， key words
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